Chronic Leukemia — Trials

Chronic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,705 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 207
Ph III recruiting: 22
Growth YoY: −13.3%
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 32.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (302)

clinicaltrialsPublishedShowing 1–50 of 92 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06524375	A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period(BRAVE)	active not recruiting	Phase 2	118	Genentech, Inc.INDUSTRY	1	Sep 28, 2026	clinicaltrials
NCT04679012	Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation	active not recruiting	Phase 2	20	Weill Medical College of Cornell University